Nkarta Inc (NKTX)

NASDAQ · Health Care

$1.56 -6.02% Close Oct 30, 2026 Live

Nkarta stock today

Nkarta closed at $1.56 on October 30, 2026, down 6.02% on the day. Over the past year it returned -25.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $112 million.

$2.00$3.00
NovJan 2026MarMayJulSep
Total return with dividends reinvested, to the close on Oct 30, 2026
PeriodNKTXS&P 500 (SPY)
1 month-40.5%-0.9%
3 months-27.4%+2.1%
Year to date-15.7%+11.7%
1 year-25.0%+12.4%
3 years-23.2%+88.5%
5 years-90.1%+76.0%

Key statistics

Market value
$112M
52-week range
$1.56 to $3.67
Next report
Nov 10, 2026 (estimated)

About Nkarta

Biopharmaceutical company developing cell therapy treatments for cancer.

Sector: Health Care

More on Nkarta

No forecast, no recommendation. This page describes Nkarta Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.